• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Precision Surgery in Patients with Colorectal Peritoneal Metastases: Bridging the Gap Between Biological Complexity and Therapeutic Options.

作者信息

Allievi Niccolo, Moran Brendan

机构信息

Peritoneal Malignancy Institute, Basingstoke North Hampshire Hospital Foundation Trust, Basingstoke, UK.

出版信息

Ann Surg Oncol. 2024 Dec;31(13):8596-8597. doi: 10.1245/s10434-024-16082-2. Epub 2024 Aug 20.

DOI:10.1245/s10434-024-16082-2
PMID:39164604
Abstract
摘要

相似文献

1
ASO Author Reflections: Precision Surgery in Patients with Colorectal Peritoneal Metastases: Bridging the Gap Between Biological Complexity and Therapeutic Options.ASO作者反思：结直肠腹膜转移患者的精准手术：弥合生物学复杂性与治疗选择之间的差距
Ann Surg Oncol. 2024 Dec;31(13):8596-8597. doi: 10.1245/s10434-024-16082-2. Epub 2024 Aug 20.
2
ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?ASO作者反思：结直肠癌腹膜转移的减瘤手术——是时候审视我们的结果了吗？
Ann Surg Oncol. 2022 Jan;29(1):203-204. doi: 10.1245/s10434-021-10701-y. Epub 2021 Aug 25.
3
ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways.ASO作者反思：单纯减瘤手术在结直肠癌腹膜转移患者中的集中化：优化治疗路径
Ann Surg Oncol. 2024 Sep;31(9):6274-6275. doi: 10.1245/s10434-024-15463-x. Epub 2024 May 18.
4
ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases.ASO作者反思：结直肠腹膜转移中潜在的治疗意义及对全身化疗病理完全缓解的预测
Ann Surg Oncol. 2021 Jul;28(7):3850-3851. doi: 10.1245/s10434-020-09378-6. Epub 2020 Nov 19.
5
ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.ASO作者反思：结直肠癌腹膜转移的组织学生长模式对接受根治性减瘤手术患者的预后有显著影响。
Ann Surg Oncol. 2024 Jul;31(7):4558-4559. doi: 10.1245/s10434-024-15206-y. Epub 2024 Mar 22.
6
ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases.
Ann Surg Oncol. 2021 Dec;28(13):9084-9085. doi: 10.1245/s10434-021-10265-x. Epub 2021 Jun 5.
7
ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases.
Ann Surg Oncol. 2021 Sep;28(9):5327-5329. doi: 10.1245/s10434-021-09601-y. Epub 2021 Jan 19.
8
ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?ASO作者反思：结直肠癌腹膜转移患者的最佳术前全身化疗方案是什么？
Ann Surg Oncol. 2023 Jun;30(6):3316-3317. doi: 10.1245/s10434-023-13214-y. Epub 2023 Feb 8.
9
ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：原发性肿瘤位置和基因组改变在结直肠癌腹膜转移及细胞减灭术-热灌注化疗中的意义
Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.
10
ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?ASO作者反思：奥沙利铂腹腔内给药在结直肠癌腹膜转移中是否仍有作用？
Ann Surg Oncol. 2022 Aug;29(8):5252-5253. doi: 10.1245/s10434-022-11657-3. Epub 2022 Mar 30.

引用本文的文献

1
Recognizing Systemic (Not Peritoneal) Recurrence May Drive Survival After Optimal Resection of Colorectal Peritoneal Metastasis (CRC-PM) and the Quest for the Surrogates that Predict Outcome.认识到系统性（而非腹膜）复发可能会影响结直肠癌腹膜转移（CRC-PM）最佳切除术后的生存率，并探寻预测预后的替代指标。
Ann Surg Oncol. 2024 Dec;31(13):8485-8487. doi: 10.1245/s10434-024-16295-5. Epub 2024 Sep 30.

本文引用的文献

1
Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.555 例结直肠腹膜转移患者行细胞减灭术和腹腔热灌注化疗的生存分析及复发模式。
Ann Surg Oncol. 2024 Dec;31(13):8585-8595. doi: 10.1245/s10434-024-15942-1. Epub 2024 Aug 11.
2
Molecular characterization of colorectal cancer related peritoneal metastatic disease.结直肠癌相关腹膜转移瘤的分子特征。
Nat Commun. 2022 Aug 4;13(1):4443. doi: 10.1038/s41467-022-32198-z.
3
The drug-induced phenotypic landscape of colorectal cancer organoids.
药物诱导的结直肠癌细胞类器官表型景观。
Nat Commun. 2022 Jun 6;13(1):3135. doi: 10.1038/s41467-022-30722-9.
4
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.随机试验的8年随访：结直肠癌腹膜转移患者的细胞减灭术及腹腔热灌注化疗与全身化疗的对比
Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.